ClearPoint Neuro Inc (CLPT)
10.93
-0.31
(-2.76%)
USD |
NASDAQ |
Nov 15, 16:00
10.94
+0.01
(+0.09%)
Pre-Market: 20:00
ClearPoint Neuro Revenue (Quarterly): 8.122M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 8.122M |
| June 30, 2024 | 7.858M |
| March 31, 2024 | 7.639M |
| December 31, 2023 | 6.81M |
| September 30, 2023 | 5.762M |
| June 30, 2023 | 5.95M |
| March 31, 2023 | 5.433M |
| December 31, 2022 | 5.174M |
| September 30, 2022 | 5.146M |
| June 30, 2022 | 5.20M |
| March 31, 2022 | 5.031M |
| December 31, 2021 | 4.282M |
| September 30, 2021 | 4.574M |
| June 30, 2021 | 3.413M |
| March 31, 2021 | 4.03M |
| December 31, 2020 | 3.716M |
| September 30, 2020 | 3.519M |
| June 30, 2020 | 2.478M |
| March 31, 2020 | 3.116M |
| December 31, 2019 | 3.211M |
| September 30, 2019 | 2.928M |
| June 30, 2019 | 2.606M |
| March 31, 2019 | 2.472M |
| December 31, 2018 | 2.276M |
| September 30, 2018 | 1.807M |
| Date | Value |
|---|---|
| June 30, 2018 | 1.646M |
| March 31, 2018 | 1.623M |
| December 31, 2017 | 1.679M |
| September 30, 2017 | 1.717M |
| June 30, 2017 | 1.976M |
| March 31, 2017 | 2.007M |
| December 31, 2016 | 1.635M |
| September 30, 2016 | 1.616M |
| June 30, 2016 | 1.104M |
| March 31, 2016 | 1.394M |
| December 31, 2015 | 1.512M |
| September 30, 2015 | 1.246M |
| June 30, 2015 | 0.8257M |
| March 31, 2015 | 1.010M |
| December 31, 2014 | 0.9598M |
| September 30, 2014 | 0.6332M |
| June 30, 2014 | 1.189M |
| March 31, 2014 | 0.8225M |
| December 31, 2013 | 1.176M |
| September 30, 2013 | 0.9275M |
| June 30, 2013 | 0.5625M |
| March 31, 2013 | 1.264M |
| December 31, 2012 | 1.863M |
| September 30, 2012 | 1.132M |
| June 30, 2012 | 1.084M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
2.478M
Minimum
Jun 2020
8.122M
Maximum
Sep 2024
5.023M
Average
5.088M
Median
Revenue (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Retractable Technologies Inc | 6.029M |
| InfuSystems Holdings Inc | 35.32M |
| Xtant Medical Holdings Inc | 29.94M |
| Catheter Precision Inc | 0.093M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.974M |
| Total Expenses (Quarterly) | 13.29M |
| EPS Diluted (Quarterly) | -0.18 |
| Enterprise Value | 279.93M |
| Gross Profit Margin (Quarterly) | 59.68% |
| Profit Margin (Quarterly) | -61.24% |
| Earnings Yield | -6.31% |
| Normalized Earnings Yield | -6.313 |